NCT00244946View on ClinicalTrials.gov

Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

January 31, 2010

Study Completion Date

March 31, 2013

Conditions
Lymphoma
Interventions
BIOLOGICAL

therapeutic autologous lymphocytes

Lymphocytes collected by standard apheresis technique either prior to or post stem cell mobilization and collection

DRUG

carmustine

DRUG

cytarabine

DRUG

etoposide

DRUG

melphalan

PROCEDURE

peripheral blood stem cell transplantation (PBSCT)

Trial Locations (1)

48201-1379

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00244946 - Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter